Chiesi Logo Vector
Chiesi has a strong track record of innovation in the pharmaceutical industry. The company has developed a number of successful new drugs, including PERIPREM (perindopril erbumine), a treatment for hypertension, and FABRAZYME (agalsidase alfa), a treatment for Fabry disease. Chiesi is also a leader in the development of new treatments for rare diseases,
